This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knudsen, J. D.
Right arrow Articles by Espersen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knudsen, J. D.
Right arrow Articles by Espersen, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Jun 1995, 1253-1258, Vol 39, No. 6
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin

JD Knudsen, N Frimodt-Moller and F Espersen
Department of Clinical Microbiology, Statens Seruminstitut, Copenhagen S, Denmark.

The purpose of the study was to investigate the correlation of in vitro activity with the in vivo effect and the pharmacokinetics of penicillin in the treatment of infections with pneumococci with various susceptibilities to penicillin. We used 10 pneumococcal strains for which penicillin MICs ranged from 0.016 to 8 micrograms/ml. Time-kill curve experiments were performed with all strains. We found that the effect of penicillin in vitro is concentration independent, with a maximum effect at two to four times the MIC for penicillin-susceptible as well as penicillin-resistant pneumococci. The mouse peritonitis model with an inoculum of approximately 10(6) CFU, to which mucin was added, resulted in a reproducible lethal infection with the pneumococci. The 50% effective dose was determined for each strain, and we found a highly significant correlation between the log MIC and the log 50% effective dose of penicillin against these strains (P < 0.01). Furthermore, it was shown that the most important pharmacokinetic parameter determining the effect of penicillin in vivo was the time that the concentration of penicillin in serum was greater than the MIC.


This article has been cited by other articles:

  • Brinch, K. S., Frimodt-Moller, N., Hoiby, N., Kristensen, H.-H. (2009). Influence of Antidrug Antibodies on Plectasin Efficacy and Pharmacokinetics. Antimicrob. Agents Chemother. 53: 4794-4800 [Abstract] [Full Text]  
  • Sandberg, A., Hessler, J. H. R., Skov, R. L., Blom, J., Frimodt-Moller, N. (2009). Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model. Antimicrob. Agents Chemother. 53: 1874-1883 [Abstract] [Full Text]  
  • Huang, Y., Yang, Z., Cartier, L., Cheung, B., Sawchuk, R. J. (2007). Estimating Amoxicillin Influx/Efflux in Chinchilla Middle Ear Fluid and Simultaneous Measurement of Antibacterial Effect. Antimicrob. Agents Chemother. 51: 4336-4341 [Abstract] [Full Text]  
  • Domenech, A., Ribes, S., Cabellos, C., Taberner, F., Tubau, F., Dominguez, M. A., Montero, A., Linares, J., Ariza, J., Gudiol, F. (2005). Experimental study on the efficacy of combinations of glycopeptides and {beta}-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides. J Antimicrob Chemother 56: 709-716 [Abstract] [Full Text]  
  • Knudsen, J. D., Odenholt, I., Erlendsdottir, H., Gottfredsson, M., Cars, O., Frimodt-Moller, N., Espersen, F., Kristinsson, K. G., Gudmundsson, S. (2003). Selection of Resistant Streptococcus pneumoniae during Penicillin Treatment In Vitro and in Three Animal Models. Antimicrob. Agents Chemother. 47: 2499-2506 [Abstract] [Full Text]  
  • Odenholt, I., Gustafsson, I., Lowdin, E., Cars, O. (2003). Suboptimal Antibiotic Dosage as a Risk Factor for Selection of Penicillin-Resistant Streptococcus pneumoniae: In Vitro Kinetic Model. Antimicrob. Agents Chemother. 47: 518-523 [Abstract] [Full Text]  
  • Rebuelto, M., Ambros, L., Rubio, M. (2003). Daily Variations in Ceftriaxone Pharmacokinetics in Rats. Antimicrob. Agents Chemother. 47: 809-812 [Abstract] [Full Text]  
  • Erlendsdottir, H., Knudsen, J. D., Odenholt, I., Cars, O., Espersen, F., Frimodt-Møller, N., Fuursted, K., Kristinsson, K. G., Gudmundsson, S. (2001). Penicillin Pharmacodynamics in Four Experimental Pneumococcal Infection Models. Antimicrob. Agents Chemother. 45: 1078-1085 [Abstract] [Full Text]  
  • Johansen, H. K., Jensen, T. G., Dessau, R. B., Lundgren, B., Frimodt-Moller, N. (2000). Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo. J Antimicrob Chemother 46: 973-980 [Abstract] [Full Text]  
  • Knudsen, J. D., Fuursted, K., Raber, S., Espersen, F., Frimodt-Møller, N. (2000). Pharmacodynamics of Glycopeptides in the Mouse Peritonitis Model of Streptococcus pneumoniae or Staphylococcus aureus Infection. Antimicrob. Agents Chemother. 44: 1247-1254 [Abstract] [Full Text]  
  • Rodriguez-Hernandez, M.-J., Pachon, J., Pichardo, C., Cuberos, L., Ibanez-Martinez, J., Garcia-Curiel, A., Caballero, F. J., Moreno, I., Jimenez-Mejias, M. E. (2000). Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother 45: 493-501 [Abstract] [Full Text]  
  • den Hollander, J. G., Knudsen, J. D., Mouton, J. W., Fuursted, K., Frimodt-Møller, N., Verbrugh, H. A., Espersen, F. (1998). Comparison of Pharmacodynamics of Azithromycin and Erythromycin In Vitro and In Vivo. Antimicrob. Agents Chemother. 42: 377-382 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»